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INTRODUCTION
American Tegumentary Leishmaniasis (ATL) is a parasitic disease caused by several protozoan species of the genus Leishmania. In Brazil, the main species responsible for ATL is Leishmania (Viannia) braziliensis, which is associated with the development of the most severe lesions of the disease, with extensive cutaneous and/or nasopharyngeal mucosal lesions (Silveira et al. 2009; Alvar et al. 2012) . Leishmania parasites are transmitted during blood meals of sandflies when infective metacyclic forms are inoculated into the skin. Parasites infect macrophages and multiply inside them. Thus, to control the infection is crucial that macrophage microbicidal mechanisms are induced. The initial interaction between parasites and macrophages may determine the outcome of infection (Handman and Bullen 2002) .
During macrophage activation, lipid mediators such as platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocoline) are fast produced. The biological effects of PAF are mediated by binding to its G protein-coupled seven α-helices transmembrane receptor (PAFR). PAFR is expressed in several kinds of cells including macrophages. Signals transduced by PAFR promote inflammation, chemotaxis, platelet aggregation, leukocytosis and adhesion of leukocytes to the vascular endothelium. PAFR activation induces mobilization of intracellular calcium and activation of different kinases (Uhlig, Göggel and Engel 2005; Shimizu 2009; Santos, Teixeira and Souza 2016) . Due to the important role of PAF in inflammation, its participation in infections has been studied and it is associated with the control and/or pathogenesis of infectious diseases, such as influenza, cerebral malaria, Chagas´disease, meningoencephalitis and dengue (Talvani et al. 2003; Souza et al. 2009; Garcia et al. 2010; Lacerda-Queiroz et al.2012; Kamaladasa et al. 2016; Vilela et al. 2016) . PAF also seems to be important for the induction of microbicidal mechanisms to control infections (Kim et al. 2008; .
Studies on the role of PAF in leishmaniasis are scarce and restricted to murine models. PAF-treated murine macrophages are resistant to infection with Leishmania amazonensis (Lonardoni, Russo and Jancar 2000; Rosa et al. 2001) . Furthermore, peritoneal macrophages of PAFR-deficient mice are more susceptible to L. amazonensis infection showing exacerbated lesions in comparison to infected wild-type mice. In the absence of PAFR, there was a decrease in nitric oxide (NO) production whereas arginase-1 expression was increased, contributing to the exacerbation of the infection (Santiago et al. 2006) . In addition, treatment with a PAF antagonist increased lesion size and parasite load in wildtype mice infected with L. amazonensis (Lonardoni, Russo and Jancar 2000) . These data suggest that PAF is produced during L. amazonensis infection and its inhibition is able to convert a resistant into a susceptible host. Moreover, microbicidal mechanisms involving other mechanism than NO production can also be induced by PAF during L. amazonensis infection (de Souza Carmo, Katz and Barbiéri 2010) .
The role of PAF in human macrophages infected with Leishmania sp. has not been evaluated. In addition, the effects of this lipid mediator on L. braziliensis infection remain unknown. Considering that L. amazonensis is able to induce PAFdependent mechanisms to control the infection in murine macrophages, we reasoned to investigate whether in human macrophages PAF can also contribute to control L. braziliensis infection. Here, we evaluated whether exogenous and endogenous PAF are important to control L. braziliensis infection in human macrophages.
MATERIALS AND METHODS

Parasites
MHOM/BR/2003/IMG Leishmania braziliensis (IMG3) parasites were obtained from a patient with localized cutaneous leishmaniasis (Leishbank IPTSP/UFG) as previously described (ZauliNascimento et al. 2010) . Parasites were cultured in Grace's Insect Medium (Sigma-Aldrich, St. Louis, MO, USA) supplemented with inactivated 20% fetal calf serum (FCS; Gibco, Life Technologies, São Paulo, SP, Brazil), 2 mM L-glutamine (Sigma-Aldrich), 100 U/mL penicillin (Sigma-Aldrich) and 100 μg/mL streptomycin (Sigma-Aldrich) at 26
• C. Parasites from stationary phase of growth (6th day of culture) were washed three times with phosphate buffer saline (PBS: 1500 g, 15 min, 10
• C) and diluted into PBS/0.1% formaldehyde (Synth, SP, Brazil) for quantification in hemocytometer. 
Monocyte-derived human macrophages
Treatment with exogenous platelet-activating factor or platelet-activating factor antagonist and infection of macrophages
Initial stationary phase-promastigote forms (6th day of culture) were resuspended in complete RPMI medium and added to the macrophages (10:1, parasite:cell). The plates were incubated at 36 • C/5% CO 2 for 4 h, washed three times with complete RPMI medium at 37
• C to remove non-internalized parasites and incubated for additional 48 h, according to Morato et al. (2014) .
To evaluate the effects of exogenous PAF, PAF (Bachem Inc., Torrence, CA, USA) was dissolved in ethanol and further diluted in PBS with 0.25% bovine serum albumin (Sigma-Aldrich). concentration used in PAF or PCA 4248 dilutions. The cytotoxicity of PAF and PCA 4248 was evaluated by MTT assay as described by Morato et al. (2014) . At the end of incubations, macrophages were stained with the Instant Prov Kit (Newprov, Pinhais, PR, Brazil) and analyzed under light microscope (1000× magnification). The frequency of infected cells (%) and mean number of parasites per infected cell were evaluated. At least 300 cells were analyzed in each coverslip. Only cells with macrophage morphology were considered during the counts (Fig. S1 , Supporting Information).
Evaluation of reactive oxygen species production and effects
NBT (nitro blue tetrazolium) assay was adapted from MunizJunqueira and de Paula-Coelho (2008) 
Statistical analysis
The data were evaluated by Wilcoxon paired test for analysis of two groups of paired samples and Kruskal-Wallis with Dunn's post-hoc test to compare three or more groups, using GraphPad Prism v.5 software (San Diego, CA, USA). Level of statistical significance was set at P < 0.05.
RESULTS
Low doses of exogenous platelet-activating factor enhance the phagocytosis of Leishmania braziliensis by human macrophages
PAF has been associated with increased phagocytic capacity of macrophages (Muehlmann et al. 2012; Lee et al. 2016) . To assess whether PAF enhances phagocytosis of Leishmania braziliensis, human macrophages were treated with PAF before or during the infection. Pre-treatment with low doses of PAF (10 −10 M) increased the percentage of infected cells evaluated after 4 h of incubation of macrophages with promastigote forms (Fig. 1A) . However, the number of parasites per infected cell was not significantly altered (Fig. 1B) . When PAF was added at the same time when parasites were added to macrophages, despite a similar profile of pre-treated macrophages, we did not observe significant changes in the phagocytosis of L. braziliensis ( Fig. 1C and D) .
Exogenous platelet-activating factor increases leishmanicidal activity of human macrophages
Since PAF is able to activate microbicidal mechanisms (Kim et al. 2008; , we investigated whether exogenous PAF treatment could lead to the control of L. braziliensis infection in human macrophages. For this, we compared the infection rates 4 h and 48 h after the incubation of macrophages with L. braziliensis. We observed an increase in the percentage of infected cells in untreated macrophages from 4 h to 48 h. However, when cells were treated with low doses of PAF (10 −10 M) before or at the time of infection, a reduction in the percentage of infected cells was observed ( Fig. 2A and C) . In addition, we observed a replication of the parasites in untreated cells (4 h vs 48 h) that was controlled by different concentrations of PAF, prior to or at the time of infection ( Fig. 2B and D) . The effect of PAF on reducing the percentage of infected cells and controlling parasite replication was also demonstrated by the infection rate at 48 h:4 h (Fig. S2 , Supporting Information) To assess whether treatment with PAF after establishment of infection would reduce parasitism in human macrophages, we infected the cells with L. braziliensis during 4 h and then PAF was added. We observed that treatment with low concentrations of PAF reduced the 48 h-increased percentage of infected cells indicating that some cells were activated to eliminate the parasites (Fig. 3A) . The 48 h-increased number of parasites per infected cell was also reduced after treatment with different concentrations of PAF but the differences were not statistically significant (Fig. 3B ).
Endogenous platelet-activating factor plays a role in the control of human macrophages infection with Leishmania braziliensis
We have observed that pre-or post-treatment with PAF increases anti-L. braziliensis activity of human macrophages. On the other side, it is possible that human macrophages produce PAF after infection with L. braziliensis and this lipid mediator can interfere with the establishment of the infection. Thus, to investigate whether endogenous PAF is important in infection control, we pretreated human macrophages with PCA 4248, a PAF antagonist. Inhibition of PAF with all concentrations of PCA 4248 increased the percentage of infected cells compared to the untreated control (Fig. 4A) . In addition, when cells were treated with 10 −5 M PCA 4248 we observed that the number of parasites per infected cell was increased in relation to the control (Fig. 4B ). Both treatments with exogenous PAF or PCA 4248 were not toxic to parasites or to human cells (Fig. 5) .
Platelet-activating factor controls Leishmania braziliensis infection in human macrophages through reactive oxygen species production
It is known that PAF can induce the production of ROS by macrophages (Huang et al. 1988) and ROS are important to control Leishmania infections, especially in human macrophages (Novais et al. 2014; Carneiro et al. 2016) . Thus, we evaluated whether exogenous PAF induces ROS production in L. braziliensis-infected human macrophages. As showed in Fig. 6 , L. braziliensis was able to induce ROS production, and pretreatment with PAF increased ROS production by infected cells. In addition, inhibition of endogenous PAF by treatment with PCA 4248 partially reversed the production of ROS induced by L. braziliensis.
To confirm that the effects of PAF are dependent on ROS production, we treated the cells with apocynin, an NADPH oxidase inhibitor, which reduces ROS production by phagocytes (Fig. 7A) . We showed that the inhibition of ROS production by apocynin reverses the effects of exogenous PAF in reducing the percentage of infected cells and the number of parasites per infected cell, after 48 h of incubation ( Fig. 7B and C) . That apocynin decreased the PAF-induced ROS in infected cells is shown in Fig. 7D .
DISCUSSION
In this study, we show for the first time that PAF plays important effects on the control of human macrophage infection by Leishmania braziliensis. We observed that low doses of exogenous PAF increased the amount of human macrophages that phagocytosed promastigotes of L. braziliensis without alteration of the number of parasites captured by cells (Fig. 1) . Phagocytosis is the first mechanism used by macrophages to control Leishmania infection and involves membrane receptors present on immune cells (Liu and Uzonna 2012; Ueno and Wilson 2012) . Thus, our results suggest that PAF increased receptors involved in Leishmania phagocytosis in some cells, increasing the number of cells that are able to uptake the parasites. In accordance with our results, previous studies have demonstrated that exogenous PAF induces phagocytosis of several microorganisms by macrophages (Ichinose et al. 1994; Soares et al. 2002; Lee et al. 2016) . It is important to note that high doses of exogenous PAF had a limited effect on the percentage of cells phagocytosing L. braziliensis but seems to reduce number of parasites per infected cell (Fig. 1) , indicating the dependence of PAF concentrations to exert its biological effects. That PAF acts depending on its concentration has been demonstrated in some studies (Kroegel et al. 1989; Hwang 1991; Pustynnikov et al. 1991; O'Flaherty, Jacobson and Redman 1992) and this is probably due to the differences in PAFRs affinities (LeVan et al. 1997; Yost, Weyrich and Zimmerman 2010; Santos, Teixeira and Souza 2016) . It has been shown that the pre-treatment of murine macrophages with low doses of PAF reduces the capture of Leishmania amazonensis (Rosa et al. 2001) . Together with our data, this suggests that different levels of activation of macrophages and/or PAFRs can lead to different consequences in the phagocytosis of L. braziliensis by human macrophages, which requires further investigation.
After the uptake of parasites, macrophage microbicidal effects are essential for infection control. We show that exogenous and endogenous PAF induces L. braziliensis death in human macrophages (Figs 2-4) . Previously, it was shown that PAF induces the killing of L. amazonensis by murine macrophages (Lonardoni, Russo and Jancar 2000; Rosa et al. 2001 ). Furthermore, PAFR-deficient mice are more susceptible to L. amazonensis infection, suggesting that PAFR signaling is essential for murine infection control (Santiago et al. 2006) . In accordance, our study improves the knowledge about the role of PAF in leishmaniasis by showing that PAF also induces microbicidal activity in L. braziliensis-infected human macrophages. The mechanisms used by human macrophages to eliminate Leishmania parasites have not yet been fully elucidated. In this study, whereas treatment with exogenous PAF increased ROS production inhibition of endogenous PAF caused a reduction in ROS induced by L. braziliensis in human macrophages (Fig. 6) . Furthermore, inhibition of ROS production by apocynin reversed the PAF-induced microbicidal effects in these cells, indicating that ROS induction is essential for leishmanicidal effect of PAF in humans (Fig. 7) . It has been demonstrated that ROS, but not NO, participates in the control of L. braziliensis infection both in monocytes from healthy donors and in lesions of patients with ATL (Novais et al. 2014) . In addition, inhibition of ROS in monocytes of patients with cutaneous leishmaniasis caused by L. braziliensis favors the growth of the parasites in these cells (Carneiro et al. 2016) . Priming with PAF increases the production of ROS inhuman neutrophils and macrophages (Hartung et al. 1983; Gardner, Laskin and Laskin 1993; Partrick et al. 1997; Verouti et al. 2011; Aquino et al. 2016) . In agreement, in this study priming with PAF and the fast PAF production after Leishmania infection led to an increase of macrophage ROS production during the first hour of infection, which was crucial for controlling parasite infection. In experiments in which the PAF antagonist was added after 4 h of infection, no significant effect was observed after 48 h of incubation (Fig. S3, Supporting Information) corroborating the suggestion that PAF is need during the first hours to contribute for L. braziliensis death. Considering NO as a microbicidal molecule produced by macrophages, it is important to stress that human macrophages produced very low levels of NO after Leishmania infection (Carneiro et al. 2016) . Nevertheless, in murine models, NO is known to play a key role in the control of Leishmania spp. Infection (Liew et al. 1990; Rocha et al. 2007; Gomes et al. 2016) and PAF increases macrophage microbicidal activity against L. amazonensis in an NO-dependent manner (Lonardoni, Russo and Jancar 2000; Santiago et al. 2006) . In addition, in mice with NADPH oxidase deficiency, the control of L. braziliensis infection is not affected, whereas iNOS deficiency leads to an increase of lesions, suggesting that NO, but not ROS, is required to kill L. braziliensis in mouse models (Rocha et al. 2007) . These results highlight the differences between mice and humans concerning mechanisms to kill Leishmania spp., which are present in different levels of relevance in human and murine macrophages, but both are upregulated by PAF. How PAF improves the production of ROS has been investigated. It is known that ROS production is upregulated by increased intracellular Ca 2+ concentration (Nunes and Demaurex 2010) and by activation of protein kinase C (Chakraborty, Ghosh and Basu 2000) . Ca 2+ is involved in the activation of the NADPH complex, acting as a second messenger in ROS pathway. Since PAF activates intracellular Ca 2+ and PKC (Huang et al. 1988) , superoxide anion production is expected to increase after PAF stimulation, as previously demonstrated in murine macrophages (Huang et al. 1988) and in equine macrophages and neutrophils (Muehlmann et al. 2012) . Thus, we can assume that these mechanisms can explain ROS increase in L. braziliensis-infected macrophages after PAF stimulation, but these mechanisms still remain to be investigated. In summary, we have shown that both endogenous and exogenous PAF increase the microbicidal activity of L. braziliensisinfected human macrophages in an ROS-dependent manner. The knowledge about the role of PAF in increasing ROS and inhibiting the growth and/or induction of death of parasites in human cells is central to improve therapeutic strategies for ATL. PAF signaling has been shown to be essential for murine visceral leishmaniasis control induced by miltefosine, an important drug in the leishmaniasis treatment (Croft, Seifert and Yardley 2006; Soto and Toledo 2007) . In those studies, PAF receptor-deficient or PAF antagonist-treated macrophages were less responsive to miltefosine losing their effects on Leishmania killing (Gangalum et al. 2015) . Thus, our data pave the way for the study of the role of PAF/PAFR signaling in human leishmaniasis caused by L. braziliensis and other species.
